AMAG Pharmaceuticals, Inc. announced the election of two new members to its Board of Directors—Anne Phillips, M.D., senior vice president, clinical development, medical and regulatory affairs for Novo Nordisk, Inc. and Kathrine O'Brien, former vice president and general manager, skin and marketing services for Unilever PLC. In addition, after serving on AMAG’s board for nearly 10 years, Lesley Russell, M.D. will not be a nominee for election at the Company's 2019 annual meeting of stockholders. Dr. Phillips' extensive clinical development background and Ms. O'Brien's broad direct-to-consumer digital marketing experience will help to support and guide AMAG's growing pipeline and its commercialized women's health products.